ICOS and neoplasm: showed that anti-PD-1 primarily promotes the expansion of exhausted-like CD8 T-cell subpopulations in tumor infiltrates, whereas anti-CTLA-4 promotes the expansion of ICOS+ Th1-like CD4 T cells on top of that (38).